← Back to Search

Health Information Exchange Platform for Improving Patient Transfers

N/A
Recruiting
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age greater than or equal to 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from time-of-day and date of transfer to time-of-day and date of hospital discharge
Awards & highlights

Study Summary

This trial is looking at whether or not an interoperable health information exchange platform can help reduce patient harm during inter-hospital transfers.

Who is the study for?
This trial is for adults over 18 who are admitted to general medicine, cardiology, oncology, or ICU services at Brigham and Women's Hospital and transferred from one of these hospitals: Brigham and Women's Faulkner Hospital, South Shore Hospital, Milford Regional Medical Center. It excludes those under 18 or admitted through ER or directly from home/clinic.Check my eligibility
What is being tested?
The trial is testing a Health Information Exchange (HIE) platform designed to improve the transfer of patient information between hospitals. The goal is to see if this system reduces medical errors by providing better access to clinical data during inter-hospital transfers.See study design
What are the potential side effects?
Since this trial involves an information technology intervention rather than a medication or medical procedure, traditional physical side effects are not applicable. However, there may be technical issues or challenges in using the platform that could indirectly affect patient care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 72 hours after transfer
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 72 hours after transfer for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total clinician-reported medical errors
Secondary outcome measures
Ameliorable clinician-reported adverse events
Clinician-reported medical errors attributable to poor information exchange
Clinician-reported quality of clinical information available
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention arm will include all included patient transfers from the 3 participating transfer hospitals to the 1 accepting hospital during the 1-year intervention phase. They will receive the intervention, which will include utilization of the developed health information exchange platform to transfer clinical information between transferring and accepting hospital. The intervention will not interact directly with the patient, but rather their clinical data.
Group II: BaselineActive Control1 Intervention
The baseline arm will include all included patient transfers from the 3 participating transfer hospitals to the 1 accepting hospital during the 1-year pre-intervention phase. They will not receive any intervention, but rather usual care

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,821,348 Total Patients Enrolled
Brigham and Women's HospitalLead Sponsor
1,615 Previous Clinical Trials
11,469,830 Total Patients Enrolled
4 Trials studying Rheumatic Diseases
2,122 Patients Enrolled for Rheumatic Diseases

Media Library

Health Information Exchange (HIE) platform Clinical Trial Eligibility Overview. Trial Name: NCT05443321 — N/A
Rheumatic Diseases Research Study Groups: Baseline, Intervention
Rheumatic Diseases Clinical Trial 2023: Health Information Exchange (HIE) platform Highlights & Side Effects. Trial Name: NCT05443321 — N/A
Health Information Exchange (HIE) platform 2023 Treatment Timeline for Medical Study. Trial Name: NCT05443321 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor currently require more participants?

"The details on clinicaltrials.gov reveal that this medical trial is not currently recruiting patients, despite being posted on October 1st 2022 and edited most recently on June 29th 2022. However, there are more than two thousand nine hundred other trials actively admitting volunteers at present."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Brigham & Women's Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Stephanie Mueller 2022. "Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05443321.
All > Pediatric Asthma > Infectious Disease
~357 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top